Breast cancer and spaceflight: Risk and management

Aviation Space and Environmental Medicine

Volumn 78, Issue 4 II, 2007, Pages

  Barr, Yael R ^a   Bacal, Kira ^b   Jones, Jeffrey A ^c   Hamilton, Douglas R ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b OHIO UNIVERSITY   (United States)

^c NASA JOHNSON SPACE CENTER   (United States)

Author keywords

Fine needle aspiration; FNA; Radiation; Spaceflight

Indexed keywords

ALPHA TOCOPHEROL; AROMATASE INHIBITOR; ASCORBIC ACID; GLUTATHIONE; MANNITOL; MELATONIN; TAMOXIFEN;

ARTICLE; ASPIRATION BIOPSY; BLEEDING; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CAPILLARY RESISTANCE; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COSMONAUT; DEEP VEIN THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; FATIGUE; HEADACHE; HOMEOSTASIS; HUMAN; IMAGING; IMMUNE FUNCTION TEST; IONIZING RADIATION; LIFESTYLE; LUNG EMBOLISM; MAMMOGRAPHY; NAUSEA; OCCUPATIONAL HAZARD; PRIMARY PREVENTION; RADIATION PROTECTION; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SPACE FLIGHT; THROMBOCYTE AGGREGATION;

AEROSPACE MEDICINE; ASTRONAUTS; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; RADIATION, IONIZING; RISK ASSESSMENT; RISK FACTORS; SPACE FLIGHT; UNITED STATES; WEIGHTLESSNESS;

EID: 34247174785     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Andrews R, Mah R. The NASA Smart Probe Project for real-time multiple microsensor tissue recognition. Stereotact Funct Neurosurg 2003; 80:114-9.
2. Anisimov V. The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 2003; 46:221-34.
3. Apantaku L. Breast cancer diagnosis and screening. Am Fam Physician 2000; 62:596-606.
4. Ballard T, Lagorio S, De Angelis G, Verdecchia A. Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med 2000; 71:216-24.
5. Barlow W, Lehman C, Zheng Y, et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 2002; 94:1151-9.
6. Blettner M, Zeeb H, Langner I, et al. Mortality from cancer and other causes among airline cabin attendants in Germany, 1960-1997. Am J Epidemiol 2002; 156:556-65.
7. Boice J, Blettner M, Auvinen A. Epidemiologic studies of pilots and aircrew. Health Phys 2000; 79:576-84.
8. Boice JJ. Radiation and breast carcinogenesis. Med Pediatr Oncol 2001; 36:508-13.
9. Bonnet M, Guinebretiere J, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999; 91:1376-81.
10. Brainard G, Kavet R, Kheifets L. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res 1999; 26:65-100.
11. Caplan LS, Schoenfeld ER, O'Leary ES, Leske MC. Breast cancer and electromagnetic fields - a review. Ann Epidemiol 2000; 10:31-44.
12. Chilvers C. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge. Drug Saf 1996; 15:212-8.
13. Cogoli A. The effect of hypogravity and hypergravity on cells of the immune system. J Leukoc Biol 1993; 54:259-68.
14. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: further results. Contraception 1996; 54(3, Suppl.):1S-106S.
15. Crucian B, Cubbage M, Sams C. Altered cytokine production by specific human peripheral blood cell subsets immediately following space flight. J Interferon Cytokine Res 2000; 20:547-56.
16. Cucinotta F, Schimmerling W, Wilson JW, et al. Space radiation cancer risk projections for exploration missions: uncertainty reduction and mitigation. Houston, TX: Lyndon B. Johnson Space Center; January 2001. Report No. JSC-29295.
17. Das D. Fine-needle aspiration cytology: its origin, development, and present status with special reference to a developing country, India. Diagn Cytopathol 2003; 28:345-51.
18. Davis S, Kaune W, Mirick D, et al. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am J Epidemiol 2001; 154:591-600.
19. Davis S, Mirick D, Stevens R. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001; 93:1557-62.
20. Davis S, Mirick D, Stevens R. Residential magnetic fields and the risk of breast cancer. Am J Epidemiol 2002; 155:446-54.
21. Dicello J, Christian A, Cucinotta F, et al. In vivo mammary tumorigenesis in the Sprague-Dawley rat and microdosimetric correlates. Phys Med Biol 2004; 49:3817-30.
22. Dijk D, Neri D, Wyatt J, et al. Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1647-64.
23. Doctor with breast cancer will be air-lifted from South Pole (Dateline October 6, 1999). Imaginis.com Breast Health News. Retrieved July 2003 from: http://imaginis.com/breasthealth/news/news10.6.99.asp?mode=1.
24. Eeles R. Future possibilities in the prevention of breast cancer - intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2000; 2:283-90.
25. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338:1089-96.
26. Eng-Wong J, Zujewski J. Raloxifene and its role in breast cancer prevention. Expert Rev Anticancer Ther 2004; 4:523-32.
27. Feeback DL, Clarke MSF. Slide-staining system for microgravity or gravity - much of the cell-staining process would be automated. Houston, TX: Lyndon B. Johnson Space Center. MSC-22949. Retrieved August 2004 from: http://www.nasatech.com/Briefs/Jan01/MSC22949.html
28. Feuer E, Wun L, Boring C, et al. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993; 85:892-7.
29. Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology 1998; 9:490-4.
30. Fine needle aspiration biopsy. Currents: physician-to-physician clinical resource, University of Iowa Health Care. Spring 2002, Vol. 3, No. 2. Retrieved July 2003 from: http://www.uihealthcare.com/news/currents/vol3issue2/ 04fineneedleaspiration.html
31. Fine needle aspiration biopsy (FNA). Imaginis.com Breast Health News. Retrieved August 2004 from: http://imaginis.com/breasthealth/biopsy/fine.asp
32. Gmunder F, Konstantinova I, Cogoli A, et al. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 1994; 65:419-23.
33. Gritzapis A, Baxevanis C, Missitzis I, et al. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay. Breast Cancer Res Treat 2003; 80:1-13.
34. Guerrero J, Reiter R. Melatonin-immune system relationships. Curr Top Med Chem 2002; 2:167-79.
35. Hahn R. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 1991; 2:208-10.
36. Haldorsen T, Reitan J, Tveten U. Cancer incidence among Norwegian airline cabin attendants. Int J Epidemiol 2001; 30:825-30.
37. Hall E. From chimney sweeps to astronauts: cancer risks in the work place. Health Phys 1998; 75:357-66.
38. Hamm P, Billica R, Johnson G, et al. Risk of cancer mortality among the Longitudinal Study of Astronaut Health (LSAH) participants. Aviat Space Environ Med 1998; 69:142-4.
39. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001; 12:74-7.
40. Hansen NM, Ye X, Grube BJ, Giuliano AE. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 2004; 139: 634-9.
41. Harm D, Jennings R, Meck J. Invited review: gender issues related to spaceflight: a NASA perspective. J Appl Physiol 2001; 91:2374-83.
42. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997; 22:87-92.
43. Hill S, Blask D. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48:6121-6.
44. Howell A, Dowsett M. Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens. Breast Cancer Res 2004; 6:269-74.
45. Huso D, Mann J, Ricart-Arbona R, et al. Chemoprevention of radiation-induced neoplasms. In: Proceedings of the Bioastronautics Investigator's Workshop; 2001 January 17-19; Galveston, TX. Retrieved August 2004 from: http://www.dsls.usra.edu/meetings/bio2001/pdf/243.pdf#search= 'Chemoprevention%20of %20Radiation Induced%20Neoplasms'
46. Huso D, Mann J, Ricart-Arbona R, et al. Countermeasures to radiation-induced neoplasms. In: Proceedings of the 14th Annual Space Radiation Health Investigators' Workshop; 2003 April 27-30; League City, TX. Retrieved August 2004 from: http://www.dsls.usra.edu/meetings/bio2003/pdf/Radiation/ 2113Huso.pdf#search='Countermeasures%20to%20radiationinduced%20neoplasms'
47. Johnson KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 2005; 117:619-28.
48. Karaer O, Oruc S, Koyuncu F. Aromatase inhibitors: possible future applications. Acta Obstet Gynecol Scand 2004; 83:699-706.
49. Kasper K. Time, distance, shielding, and radioprotectants. Health Phys 2004; 87:1-2.
50. Kaunitz A. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. J Reprod Med 1996; 41(5, Suppl.):419-27.
51. Kaunitz A. Long-acting injectable contraception with depot medroxyprogesteroneacetate. Am J Obstet Gynecol 1994; 170:1543-9.
52. Key TJ, Appelby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218-26.
53. Kramer R, Brown P. Should tamoxifen be used in breast cancer prevention? Drug Saf 2004; 27:979-89.
54. Kubba A. Breast cancer and the pill. J R Soc Med 2003; 96:280-3.
55. Land C. Low-dose radiation - a cause of breast cancer? Cancer 1980; 46(4, Suppl.):868-73.
56. Lavin M. Role of the ataxia-telangiectasia gene (ATM) in breast cancer. Br J Med 1998; 317:486-7.
57. Lee N, Rosero-Bixby L, Oberle M, et al. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst 1987; 6:1247-54.
58. Leong SPL. Selective sentinel lymphadenectomy for breast cancer in the United States. Asian J Surg 2004; 27:268-74.
59. Linnersjo A, Hammar N, Dammstrom B, et al. Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med 2003; 60:810-4.
60. Lynge E. Commentary: cancer in the air. Int J Epidemiol 2001; 30:830-2.
61. Lynge E. Risk of breast cancer is also increased among Danish female airline cabin attendants [Letter]. Br J Med 1996; 312:253.
62. Makhoul I, Makhoul H. Breast cancer. eMedicine.com. Retrieved August 2004 from: http://www.emedicine.com/med/topic2808.htm
63. Mawson A. Breast cancer in female flight attendants [Letter]. Lancet 1998; 352:626.
64. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142:37-46.
65. National Comprehensive Cancer Network (NCCN). Breast cancer. In: Clinical practice guidelines in oncology, v. 1. Jenkintown, PA: NCCN; 2004.
66. National Comprehensive Cancer Network (NCCN). Breast cancer risk reduction. In: Clinical practice guidelines in oncology, v. 1. Jenkintown, PA: NCCN; 2004.
67. NCRP. National Council on Radiation Protection and Measurements. Radiation protection guidance for activities in low Earth orbit. Bethesda, MD: NCRP; 2000. NCRP Report No. 132.
68. Nielsen J, Vollers M. Ice bound: a doctor's incredible battle for survival at the South Pole. New York: Miramax Books; 2002.
69. Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Sheffield, UK: NHS Cancer Screening Programmes, NHSBSP; 2001. Publication No.: NHSBSP 50.
70. Paul C, Skegg D, Spears G. Depot medroxyprogesterone (Depo Provera) and risk of breast cancer. Br Med J 1989; 299:759-62.
71. Pieri C, Moroni F, Marra M, et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 1995; 20:159-65.
72. Preston D, Mattsson A, Holmberg E, et al. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002; 158:220-35.
73. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. Br J Med 1995; 311:649-52.
74. Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J. Breast cancer risk in airline cabin attendants: a nested case control study in Iceland. Occup Environ Med 2003; 60:807-9.
75. Rafnsson V, Tulinius H, Jonasson J, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001; 12:95-101.
76. Reiter R, Tan D, Gitto E, et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 2004; 56:159-70.
77. Reynolds P, Cone J, Layefsky M, et al. Cancer incidence in California flight attendants (United States). Cancer Causes Control 2002; 13:317-24.
78. Reynolds P, Hurley S, Goldberg DE, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004; 96:29-37.
79. Rosenbloom M. Toxicity, vitamin. eMedicine.com. Retrieved December 2005 from: http://www.emedicine.com/emerg/topic638.htm
80. Roussel F, Nouvet G. Evaluation of large-needle biopsy for the diagnosis of cancer. Acta Cytol 1995; 39:449-52.
81. Rykova M, Sonnenfeld G, Lesnyak AT, et al. Effects of spaceflight on natural killer cell activity. J Appl Physiol 1992; 73(2, Suppl.):196S-200S.
82. San Diego State University and the California Department of Health Services, Cancer Detection Section. Breast diagnostic algorithms for primary care clinicians. Retrieved July 2004 from: http://qap.sdsu.edu/screening/ breastcancer/bda/index.html
83. Schernhammer E, Laden F, Speizer F, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001; 93:1563-8.
84. Schernhammer E, Rosner B, Willett W, et al. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004; 13:936-43.
85. Seed T, Kumar S, Whitnall M. New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel. J Radiat Res 2002; 43:S239-44.
86. Shapiro S, Rosenberg L, Hoffman M, et al. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol 2000; 151:396-403.
87. Simonsen L, Wilson J, Kim M. Radiation exposure for human Mars exploration. Health Physics 2000; 79:515-25.
88. Singhal H, Thomson S. Breast cancer evaluation. eMedicine.com. Retrieved July 2004 from: http://www.emedicine.com/med/topic3287.htm
89. Sitruk-Ware R, Plu-Bureau G. Exogenous progestagens and the human breast. Maturitas 2004; 49:58-66.
90. Skegg D, Noonan E, Paul C, et al. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA 1995; 273:799-804.
91. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995; 75:1619-26.
92. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53:141-69.
93. Sonnenfeld G. Immune responses in space flight. Int J Sports Med 1998; 19(Suppl. 3):S195-202.
94. Sonnenfeld G. The immune system in space and microgravity. Med Sci Sports Exerc 2002; 34:2021-7.
95. Sonnenfeld G, Butel J, Shearer W. Effects of the space flight environment on the immune system. Rev Environ Health 2003; 18:1-17.
96. Sonnenfeld G, Mandel A, Konstantinova I, et al. Spaceflight alters immune cell function and distribution. J Appl Physiol 1992; 73(2, Suppl.):191S-5S.
97. Sonnenfeld G, Shearer W. Immune function during space flight. Nutrition 2002; 18:899.
98. Sporn MB, Dowsett SA, Mershon J, Bryant HU. Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action. Clin Ther 2004; 26:830-40.
99. Staffa JA, Newschaffer CJ, Jones JK, Miller V. Progestins and breast cancer: an epidemiologic review. Fertil Steril 1992; 57:473-91.
100. Stanford M, Jones J. Space radiation concerns for manned exploration. Acta Astronaut 1999; 45:39-47.
101. Stavros A, Thickman D, Rapp C, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196:123-34.
102. Stevens R, Davis S. The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 1996; 104(Suppl. 1):135-40.
103. Stevens R, Davis S, Thomas D, et al. Electric power, pineal function, and the risk of breast cancer. FASEB J 1992; 6:853-60.
104. Stowe RP, Pierson DL, Feeback DL, Barrett AD. Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation 2000; 8:51-8.
105. Strom B, Berlin J, Weber A, et al. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer. Contraception 2004; 69:353-60.
106. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute web site. Retrieved August 2004 from: http://seer.cancer.gov/
107. Tabar L, Fagerberg G, Chen H, et al. Efficacy of breast cancer screening by age. New results from the Swedish two-county trial. Cancer 1995; 75:2507-17.
108. Tabar L, Vitak B, Chen H, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91:1724-31.
109. Tamarkin L, Cohen M, Roselle D, et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a) anthracene-induced mammary tumors in the rat. Cancer Res 1981; 41:4432-6.
110. Taylor G, Janney R. In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J Leukoc Biol 1992; 51:129-32.
111. Thomas D, Noonan L, Whitehead A, et al. Breast cancer and depot-medroxyprogesterone acetate: a multinational study. Lancet 1991; 338:833-8.
112. Townsend L, Fry R. Radiation protection guidance for activities in low-Earth orbit. Adv Space Res 2002; 30:957-63.
113. Trentham D. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 2000; 11:533-42.
114. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996; 7:197-204.
115. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 1996.
116. Vernikos J. Pharmacological approaches. Acta Astronaut 1995; 35:281-95.
117. Vijayalaxmi, Reiter R, Tan D, et al. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys 2004; 59:639-53.
118. Wartenberg D, Stapleton C. Risk of breast cancer is also increased among retired US female airline cabin attendants [Letter]. Br J Med 1998; 316:1902.
119. Whelan E. Cancer incidence in airline cabin crew. Occup Environ Med 2003; 60:805-6.
120. Zeeb H, Blettner M, Langner I, et al. Mortality from cancer and other causes among airline cabin attendants in Europe: a collaborative cohort study in eight countries. Am J Epidemiol 2003; 158:35-46.